Molecular Minimal Residual Disease in Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a heterogeneous group of clonal hematopoietic stem-cell disorders with a variable response to therapy. Although the majority of patients with newly diagnosed AML have morphologic complete remission after they are treated with intensive induction chemotherapy, relapse…

from Cancer via ola Kala on Inoreader https://ift.tt/2J3ak6b
via IFTTT